104 related articles for article (PubMed ID: 29194596)
21. Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.
Dong Z; Liu Y; Levin L; Oleksowicz L; Wang J; Lu S
Oncol Rep; 2011 Jun; 25(6):1511-6. PubMed ID: 21455584
[TBL] [Abstract][Full Text] [Related]
22. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
[TBL] [Abstract][Full Text] [Related]
23. Rad6 upregulation promotes stem cell-like characteristics and platinum resistance in ovarian cancer.
Somasagara RR; Tripathi K; Spencer SM; Clark DW; Barnett R; Bachaboina L; Scalici J; Rocconi RP; Piazza GA; Palle K
Biochem Biophys Res Commun; 2016 Jan; 469(3):449-55. PubMed ID: 26679603
[TBL] [Abstract][Full Text] [Related]
24. VAV3 in human cancers: Mechanism and clinical implication.
Al-Hawary SIS; Alsalamy A; Gupta R; Alsaab HO; Hjazi A; Edilboyev U; Ramadan MF; Hussien BM; Ahmed M; Hosseini-Fard SR
Pathol Res Pract; 2023 Aug; 248():154681. PubMed ID: 37467637
[TBL] [Abstract][Full Text] [Related]
25. Vav1 increases Bcl-2 expression by selective activation of Rac2-Akt in leukemia T cells.
Wan YJ; Yang Y; Leng QL; Lan B; Jia HY; Liu YH; Zhang CZ; Cao Y
Cell Signal; 2014 Oct; 26(10):2202-9. PubMed ID: 24880064
[TBL] [Abstract][Full Text] [Related]
26. Vav3 is regulated during the cell cycle and effects cell division.
Fujikawa K; Inoue Y; Sakai M; Koyama Y; Nishi S; Funada R; Alt FW; Swat W
Proc Natl Acad Sci U S A; 2002 Apr; 99(7):4313-8. PubMed ID: 11917103
[TBL] [Abstract][Full Text] [Related]
27. Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients.
Eitan R; Kushnir M; Lithwick-Yanai G; David MB; Hoshen M; Glezerman M; Hod M; Sabah G; Rosenwald S; Levavi H
Gynecol Oncol; 2009 Aug; 114(2):253-9. PubMed ID: 19446316
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the guanine nucleotide exchange factor Vav3 in central nervous system development and plasticity.
Ulc A; Gottschling C; Schäfer I; Wegrzyn D; van Leeuwen S; Luft V; Reinhard J; Faissner A
Biol Chem; 2017 May; 398(5-6):663-675. PubMed ID: 28214347
[TBL] [Abstract][Full Text] [Related]
29. Tumor recurrence and drug resistance properties of side population cells in high grade ovary cancer.
Zhang QH; Dou HT; Xu P; Zhuang SC; Liu PS
Drug Res (Stuttg); 2015 Mar; 65(3):153-7. PubMed ID: 25504004
[TBL] [Abstract][Full Text] [Related]
30. VAV3 oncogene expression in colorectal cancer: clinical aspects and functional characterization.
Uen YH; Fang CL; Hseu YC; Shen PC; Yang HL; Wen KS; Hung ST; Wang LH; Lin KY
Sci Rep; 2015 Mar; 5():9360. PubMed ID: 25791293
[TBL] [Abstract][Full Text] [Related]
31. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
32. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers.
Notaro S; Reimer D; Fiegl H; Schmid G; Wiedemair A; Rössler J; Marth C; Zeimet AG
BMC Cancer; 2016 Aug; 16():589. PubMed ID: 27485273
[TBL] [Abstract][Full Text] [Related]
34. The Rho protein exchange factor Vav3 regulates vascular smooth muscle cell proliferation and migration.
Toumaniantz G; Ferland-McCollough D; Cario-Toumaniantz C; Pacaud P; Loirand G
Cardiovasc Res; 2010 Apr; 86(1):131-40. PubMed ID: 19969623
[TBL] [Abstract][Full Text] [Related]
35. Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling.
Jiang K; Lu Q; Li Q; Ji Y; Chen W; Xue X
Int Immunopharmacol; 2017 Jan; 42():195-202. PubMed ID: 27930970
[TBL] [Abstract][Full Text] [Related]
36. The clinical value of Vav3 in peripheral blood for predicting lymphatic metastasis of gastric cancer.
Tan B; Li Y; Wang C; Tan M; Fan L; Zhao Q; Wang D; Jia N
Br J Biomed Sci; 2017 Jul; 74(3):133-137. PubMed ID: 28513273
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway.
Tan B; Li Y; Zhao Q; Fan L; Liu Y; Wang D; Zhao X
Cancer Gene Ther; 2014 Dec; 21(12):526-31. PubMed ID: 25430880
[TBL] [Abstract][Full Text] [Related]
38. Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer.
Noske A; Kaszubiak A; Weichert W; Sers C; Niesporek S; Koch I; Schaefer B; Sehouli J; Dietel M; Lage H; Denkert C
Cancer Lett; 2007 Feb; 246(1-2):190-200. PubMed ID: 16584837
[TBL] [Abstract][Full Text] [Related]
39. A Novel Vav3 Homolog Identified in Lamprey, Lampetra japonica, with Roles in Lipopolysaccharide-Mediated Immune Response.
Shen Y; Zhang Y; Han Y; Su P; Gou M; Pang Y; Li Q; Liu X
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937614
[TBL] [Abstract][Full Text] [Related]
40. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
